Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RKLB
2. ACVA
3. SPY
4. CRWV
5. RIOT
6. RPD
7. NVDA
8. HIMS
9. FERG
10. BBIO

Go back to Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 4.45 -0.02 (0.45%)
Previous Close $4.47    52 Week High $44.38 
Open $4.47    52 Week Low $24.47 
Day High $4.53    P/E 222.50 
Day Low $4.37    EPS $0.02 
Volume 1,755,397       

LIGAND PHARMA (NASDAQ: LGND) Delayed: 288.75 -6.95 (2.35%)
Previous Close $295.70    52 Week High $139.79 
Open $295.01    52 Week Low $82.07 
Day High $299.34    P/E 671.51 
Day Low $288.60    EPS $0.43 
Volume 368,556